Last reviewed · How we verify
NCT05748379
Atraumatic Zirconia Abutment Versus Customized Composite Healing Abutment in Maxilla or Mandible.
NA trial testing Kompozite closure in Dental Implants in 44 participants. Participants enrolled and being followed up; not accepting new ones.
22 May 2024
Quick facts
| Lead sponsor | SIA Adenta |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 44 |
| Start date | 28 February 2023 |
| Primary completion | 22 May 2024 |
| Estimated completion | 22 May 2025 |
| Sites | 1 location across Latvia |
Drugs / interventions tested
- Kompozite closure
- Individual abutment
Conditions studied
- Dental Implants — all drugs for Dental Implants →
- Humans — all drugs for Humans →
- Dental Implants, Single-Tooth — all drugs for Dental Implants, Single-Tooth →
- Male — all drugs for Male →
Sponsor
SIA Adenta
Who can join
18 and older, any sex, with Dental Implants or Humans. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
40 patients are included in the study, 20 patients in group 1 (=closure with composite material shaper; test group) and 20 patients in group 2 (=closure with custom-made zirconia oxide abutment; control group). Randomisation envelopes will be used for randomisation. Device under study: Straumann BLX, Roxolid® , SLActive® dental implants with a diameter of 3.5, 3.75, 4, 4.5 mm are used. Allogenic bone botiss maxgraft® cortical granules are used as graft material. Inclusion criteria: 1. Males and females at least 18 years of age or older. 2. One implant per patient. 3. Prior to any study-related activity, the subject must voluntarily sign informed consent, be willing and able to attend scheduled follow-up visits, and agree to the collection and analysis of pseudonymised data. 4. Lateral individual teeth (premolars and molars). 5. Class I extraction socket (intact buccal wall) or class II (1/3 of buccal wall). 6. The gingival contour of the tooth to be extracted - without recession. 7. Adjacent anterior teeth have no periodontal loss. 8. There are no implants in the adjacent teeth. 9. Non-traumatic tooth extraction, which results in intact walls of the socket. Exclusion criteria: 1. Deep occlusion (severe, class II). 2. The patient smokes a lot (more than 10 cigarettes per day). 3. Systemic disease (osteoporosis). 4. No initial stability has been achieved after the implant insertion procedure.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Chairside vs Prefabricated Sealing Socket Abutments for Posterior Immediate Implants: A Randomized Clinical Trial.
Gnusins V, Akhondi S, Zvirblis T, Pala K, et al · · 2025 · cited 1× · PMID 40692347 · DOI 10.1111/cid.70076
Verify or expand the search:
- PubMed search for NCT05748379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Implants
Currently open trials in the same condition.
- NCT07346391 — Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibr · NA · recruiting
- NCT07073196 — Single Implant Crowns Supported by Narrow or Standard Diameter Implants in Molar Sites · NA · recruiting
- NCT06808854 — Variable-thread Versus Standard Dental Implants for Replacing Missing Teeth · NA · recruiting
- NCT07088679 — Natural Bioactive Gel for Peri-Implantitis · NA · recruiting
- NCT06960460 — Study Evaluating the Performance and Safety in the Medium and Long Term of Global D ZygoFixU System · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05748379 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SIA Adenta
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing